DOWNLOAD the newest ValidTorrent CIC PDF dumps from Cloud Storage for free: https://drive.google.com/open?id=199hzW_Y0ksm8HhPf3OKRGXiBnjF07bEy
ValidTorrent offers highly designed CBIC CIC exam questions and online CIC practice test engine to help you successfully clear the CBIC exam. Their study materials cover all the basic to advanced required CIC Exam Questions material that you need to know to pass the CIC Exam. These two simple, easy, and accessible learning formats will boost your confidence.
| Section | Weight | Objectives |
|---|---|---|
| Employee/Occupational Health | 10-13% | |
| Environment of Care | 10-13% | |
| Identification of Infectious Disease Processes | 17-19% | |
| Surveillance and Epidemiologic Investigation | 22-26% | |
| Education and Research | 6-9% | |
| Cleaning, Sterilization, Disinfection, Asepsis | 10-13% | |
| Management and Communication | 10-13% | |
| Preventing/Controlling the Transmission of Infectious Agents | 17-19% |
One more thing to give you an idea about the top features of CBIC Certified Infection Control Exam (CIC) exam questions before purchasing, the ValidTorrent are offering free ValidTorrent CIC Exam Questions demo download facility. This facility is being offered in all three ValidTorrent CIC exam practice question formats.
NEW QUESTION # 199
An 84-year-old male with a gangrenous foot is admitted to the hospital from an extended-care facility (ECF).
The ECF is notified that the wound grew Enterococcus faecium with the following antibiotic sensitivity results:
ampicillin - R
vancomycin - R
penicillin - R
linezolid - S
This is the fourth Enterococcus species cultured from residents within the same ECF wing in the past month.
The other cultures were from two urine specimens and a draining wound. The Infection Preventionist (IP) should immediately:
Answer: B
Explanation:
The scenario describes a potential outbreak of multidrug-resistant Enterococcus faecium in an extended-care facility (ECF) wing, indicated by four positive cultures (including the current case and three prior cases from urine and a draining wound) within a month. The organism exhibits resistance to ampicillin, vancomycin, and penicillin, but sensitivity to linezolid, suggesting a possible vancomycin-resistant Enterococcus (VRE) strain, which is a significant concern in healthcare settings. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the importance of rapid outbreak detection and response in the
"Surveillance and Epidemiologic Investigation" domain, aligning with Centers for Disease Control and Prevention (CDC) guidelines for managing multidrug-resistant organisms (MDROs).
Option A, "Notify the medical director of the outbreak," is the most immediate and critical action. Identifying an outbreak-defined by the CDC as two or more cases of a similar illness linked by time and place-requires prompt notification to the facility's leadership (e.g., medical director) to initiate a coordinated response. The presence of four Enterococcus cases, including a multidrug-resistant strain, within a single ECF wing over a month suggests a potential cluster, necessitating urgent action to assess the scope, implement control measures, and allocate resources. The CDC's "Management of Multidrug-Resistant Organisms in Healthcare Settings" (2006) recommends immediate reporting to facility leadership as the first step to activate an outbreak investigation team, making this the priority.
Option B, "Compare the four culture reports and sensitivity patterns," is an important subsequent step in outbreak investigation. Analyzing the antibiotic susceptibility profiles and culture sources can confirm whether the cases are epidemiologically linked (e.g., clonal spread of VRE) and guide treatment and control strategies. However, this is a detailed analysis that follows initial notification and should not delay alerting the medical director. Option C, "Conduct surveillance cultures for this organism in all residents," is a proactive measure to determine the prevalence of Enterococcus faecium, especially VRE, within the wing. The CDC recommends targeted surveillance during outbreaks, but this requires prior authorization and planning by the outbreak team, making it a secondary action after notification. Option D, "Notify the nursing administrator to close the wing to new admissions," may be a control measure to prevent further spread, as suggested by the CDC for MDRO outbreaks. However, closing a unit is a significant decision that should be guided by the medical director and infection control team after assessing the situation, not an immediate independent action by the IP.
The CBIC Practice Analysis (2022) and CDC guidelines prioritize rapid communication with leadership to initiate a structured outbreak response, including resource allocation and policy adjustments. Given the multidrug-resistant nature and cluster pattern, notifying the medical director (Option A) is the most immediate and appropriate action to ensure a comprehensive response.
References:
* CBIC Practice Analysis, 2022.
* CDC Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006.
NEW QUESTION # 200
When evaluating environmental cleaning and disinfectant products as a part of the product evaluation committee, which of the following is responsible for providing information regarding clinical trials?
Answer: A
Explanation:
The correct answer is D, "Manufacturer representatives," as they are responsible for providing information regarding clinical trials when evaluating environmental cleaning and disinfectant products as part of the product evaluation committee. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, manufacturers are the primary source of data on the efficacy, safety, and performance of their products, including clinical trial results that demonstrate the disinfectant's ability to reduce microbial load or prevent healthcare-associated infections (HAIs) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols).
This information is critical for the committee to assess whether the product meets regulatory standards (e.g., EPA registration) and aligns with infection prevention goals, and it is typically supported by documentation such as peer-reviewed studies or trial data provided by the manufacturer.
Option A (Infection Preventionist) plays a key role in evaluating the product's fit within infection control practices and may contribute expertise or conduct internal assessments, but they are not responsible for providing clinical trial data, which originates from the manufacturer. Option B (Clinical representatives) can offer insights into clinical usage and outcomes but rely on manufacturer data for trial evidence rather than generating it. Option C (Environmental Services) focuses on the practical application and cleaning processes but lacks the authority or resources to conduct or provide clinical trial information.
The reliance on manufacturer representatives aligns with CBIC's emphasis on evidence-based decision- making in product selection, ensuring that the product evaluation committee bases its choices on robust, manufacturer-supplied clinical data (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies).
This approach supports the safe and effective implementation of environmental cleaning products in healthcare settings.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies; Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols.
NEW QUESTION # 201
A patient who is pregnant has multidrug-resistant tuberculosis. She presents to the hospital for delivery. She continues to have a productive cough and has sputum smears positive for acid-fast bacilli (AFB), despite treatment. An infection preventionist should recommend which of the following?
Answer: B
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) addresses management of tuberculosis (TB) in the peripartum setting, emphasizing protection of the neonate while supporting maternal-infant bonding when safely possible. In this scenario, the mother has active, infectious multidrug-resistant TB, as evidenced by persistent productive cough and positive AFB smears, and therefore requires Airborne Precautions.
Newborns are at high risk for TB infection due to immature immune systems; however, complete and prolonged separation is not always required. The recommended approach is to initially place the infant in Airborne Precautions in the nursery and allow limited, controlled contact with the mother once appropriate safeguards are in place. When the infant is brought to the mother's room, the mother must wear a surgical mask to reduce droplet nuclei exposure, and exposure time should be minimized.
Option A is overly restrictive and not required unless safe controls cannot be maintained. Option B is incorrect because unrestricted rooming-in places the infant at unacceptable risk. Option D is incorrect because the infant does require protection when the mother is infectious.
For the CIC exam, it is critical to recognize that TB management balances infection prevention with family- centered care. Controlled infant exposure with maternal masking is the recommended practice when mothers remain infectious at delivery.
NEW QUESTION # 202
Steam sterilization should be validated with which of the following organisms?
Answer: B
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly states that steam sterilization (moist heat sterilization) must be validated using biological indicators containing Geobacillus stearothermophilus spores. This organism is selected because its spores are highly resistant to moist heat, making them an ideal challenge organism for assessing the effectiveness of steam sterilization processes.
Biological indicators are used to confirm that sterilization conditions-such as temperature, pressure, and exposure time-are sufficient to achieve microbial inactivation. Geobacillus stearothermophilus thrives at high temperatures and demonstrates strong resistance to steam, so if these spores are destroyed, it provides high confidence that other less-resistant microorganisms, including bacteria, viruses, and fungi, have also been eliminated.
The other options are incorrect for steam sterilization validation. Staphylococcus aureus is a vegetative bacterium and is far less resistant than bacterial spores. Bacillus anthracis is not used as a biological indicator due to safety concerns and lack of standardization. Bacillus atrophaeus is used as the biological indicator for dry heat and ethylene oxide sterilization, not steam.
Understanding which biological indicators correspond to specific sterilization modalities is a high-yield topic on the CIC exam and is essential for ensuring compliance with evidence-based sterilization and disinfection standards.
=======
NEW QUESTION # 203
An infection preventionist (IP) meets with the operating room staff to discuss an increased number of patients with infections caused by different organisms after joint replacement surgeries. After reviewing case records, the operating room staff members note compliance with operating room standards. Which of the following options BEST explains this discrepancy?
Answer: B
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly differentiates between process measures and outcome measures in infection prevention and quality improvement. Process indicators measure whether specific practices or standards are being followed, such as adherence to operating room protocols, environmental controls, or sterile technique. Outcome indicators, on the other hand, reflect the end result, such as the occurrence of surgical site infections (SSIs).
In this scenario, operating room staff demonstrate compliance with established standards, yet an increase in post-joint replacement infections is observed. This discrepancy is best explained by the principle that process compliance alone does not guarantee desired outcomes. Even when processes appear to be correctly followed, infections may still occur due to factors outside the measured processes, such as patient-related risk factors, organism virulence, antimicrobial resistance, or unmeasured system variables.
Options A and B incorrectly focus on personnel competency rather than measurement limitations. Option D may affect data interpretation but does not explain why compliant processes fail to correlate with outcomes.
The Study Guide emphasizes that outcome measures are influenced by multiple interacting variables, and therefore a single set of process indicators may not fully explain infection trends.
For the CIC exam, it is critical to understand that process measures support improvement but do not always predict outcomes, highlighting the need for comprehensive analysis when infection rates rise despite apparent compliance.
NEW QUESTION # 204
......
The CBIC Certified Infection Control Exam (CIC) exam dumps are real and updated CIC exam questions that are verified by subject matter experts. They work closely and check all CIC exam dumps one by one. They maintain and ensure the top standard of ValidTorrent CIC Exam Questions all the time. The CIC practice test is being offered in three different formats. These CIC exam questions formats are PDF dumps files, web-based practice test software, and desktop practice test software.
Reliable CIC Study Notes: https://www.validtorrent.com/CIC-valid-exam-torrent.html
BONUS!!! Download part of ValidTorrent CIC dumps for free: https://drive.google.com/open?id=199hzW_Y0ksm8HhPf3OKRGXiBnjF07bEy